KolateAI drives accelerated and targeted pharma clinical trials with our trial events prediction engine and Co-pilot that enable in-trial course correction - our goal is to mitigate the 90% clinical dev failure rate & $1-2B cost per drug. We can assist in stopping non-working trials early or in streamlining working trials. With our predictions of AE’s, drug response, and trial end-points, working in concert with our Gen AI Co-pilot, we can (1) identify best-performing patient cohorts in advance (2) provide advance view of trial direction by comparison of treatment vs control trial arms, & (3) enable effective real-time trial management.